Followers | 76 |
Posts | 3712 |
Boards Moderated | 0 |
Alias Born | 10/23/2010 |
Tuesday, November 23, 2010 12:59:55 AM
Over the past 12 months, Brigham has risen 128% versus an S&P 500 return of 11.3%. Investors in Brigham have every reason to be proud of their returns, but is it time to take some off the top? Not necessarily.
Recent Price $24.46
52-Week High $25.75
5-Year High $25.80
While I would love to be all cheer here there are a number of factors that are worth watching over the next few quarters that should dictate whether we continue our streak or not.
First the price / earnings ration has substantially growth over the last few years to over 80. What is keeping this moving is the strong growth prospects. Then there has been a gradual decline in their gross margins over the last few years but as we all know this has been main street for many stocks during the "great recession". Here, short interest is at a high 8.4%. This typically indicates that large institutional investors are betting against the stock. I consider a debt-to-equity ratio below 50% to be healthy, though it varies by industry. Brigham is slightly above this level, at 53.2%.
Does this mean we should take profits and sell? I wouldn't go that far, this one has a lot of upside based on commodity price increases in 2011 and new developments but I do recommend you keep an eye on these factors mentioned above that will impact this stock one way or another.
Check out what others are saying:
http://caps.fool.com/Ticker/BEXP/Commentary/Page1.aspx
This is not an offer to buy or sell securities or any kind of investment advice. Oil investment carries very high risks so consult a licensed professional making any decisions. My track record is real time @TurnKeyOil
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM